Visalakshi Chandramouli is the Founding member and head of Tata Capital Healthcare Fund, an India dedicated Healthcare & Life Sciences Private Equity Fund. She has spent over twenty-eight years across Healthcare Private Equity, Equity Research and Pharmaceutical R&D operations. Visalakshi has successfully led the fund raise of Tata Capital Healthcare Funds I and II with commitments in excess of USD 200MN from international and domestic institutional investors and corporates. She is actively involved in portfolio management through presence on Board and other committees of Investee companies. Under her leadership Tata Capital Healthcare Fund has delivered a robust performance track record for which the Fund has been awarded ‘Healthcare Investor of the Year’ for three consecutive years, 2018, 2019 and 2020 by Venture Intelligence.
Chandramouli started her career as a research scientist at Cipla, a global pharmaceutical company and thereafter, spent over 12 years as Lead Healthcare investment analyst at leading financial services firms like Kotak Securities and Merrill Lynch where she was Senior Director of India Healthcare Equity Research and rated No. 2 in Asia for Healthcare for 2008 on the prestigious Institutional Investor (II) poll rankings. Visalakshi brings on board a deep experience of technical skills within the pharmaceutical industry as well as commercial & investment experience in the industry.
Visalakshi is a Chemical Technologist from ICT Mumbai (specialization in pharmaceuticals & fine chemicals) and MBA (finance) from Mumbai University. She is a graduate in Advanced Management Program (AMP) from the Harvard Business School. Visalakshi has also been recognized as ‘India’s Top 100 Women in Finance’ by AIWMI (Oct.’2020). Visalakshi is also actively involved with industry associations like NatHealth as co-chair Western Region and as co-chair of Impact Future Project (IFP).